Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Sponsor and Collaborators
Cancer and Leukemia Group B
National Cancer Institute (NCI)
Click here for contacts and locations
George Philips, MD, MPH University of Vermont
Next post in Kidney Cancer Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.